Sensei Biotherapeutics Appoints New CMO, Director
Ticker: SNSE · Form: 8-K · Filed: Apr 2, 2024 · CIK: 1829802
| Field | Detail |
|---|---|
| Company | Sensei Biotherapeutics, Inc. (SNSE) |
| Form Type | 8-K |
| Filed Date | Apr 2, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-appointment
TL;DR
Sensei Bio brings in a new CMO and adds a director to the board.
AI Summary
Sensei Biotherapeutics, Inc. announced on March 27, 2024, the appointment of Dr. John W. Miller as Chief Medical Officer and the election of Ms. Jennifer L. Jones to its Board of Directors. The company also disclosed compensatory arrangements for its named executive officers, though specific dollar amounts were not detailed in this filing.
Why It Matters
These executive and board changes can signal shifts in strategic direction and leadership within the company, potentially impacting its future development and operational focus.
Risk Assessment
Risk Level: medium — Changes in key leadership and board composition can introduce uncertainty regarding future strategy and execution.
Key Players & Entities
- Sensei Biotherapeutics, Inc. (company) — Registrant
- Dr. John W. Miller (person) — Appointed Chief Medical Officer
- Ms. Jennifer L. Jones (person) — Elected to Board of Directors
- March 27, 2024 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer for Sensei Biotherapeutics?
Dr. John W. Miller has been appointed as the new Chief Medical Officer.
Who has been elected to the Board of Directors at Sensei Biotherapeutics?
Ms. Jennifer L. Jones has been elected to the Board of Directors.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is March 27, 2024.
What is the principal executive office address for Sensei Biotherapeutics?
The principal executive office is located at 1405 Research Blvd, Suite 125, Rockville, MD 20850.
What is the telephone number for Sensei Biotherapeutics?
The telephone number is (240) 243-8000.
Filing Stats: 428 words · 2 min read · ~1 pages · Grade level 12.7 · Accepted 2024-04-02 07:45:54
Filing Documents
- d821191d8k.htm (8-K) — 22KB
- 0001193125-24-084096.txt ( ) — 144KB
- snse-20240327.xsd (EX-101.SCH) — 3KB
- snse-20240327_lab.xml (EX-101.LAB) — 18KB
- snse-20240327_pre.xml (EX-101.PRE) — 11KB
- d821191d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Sensei Biotherapeutics, Inc. Date: April 2, 2024 /s/ Christopher W. Gerry Christopher W. Gerry General Counsel and Secretary 3